Johnson & Johnson Innovative Medicine Ringaskiddy[1] has announced Abode, a services and support provider to adults living with disabilities, as its charity partner for 2025. Through this partnership, J&J will provide meaningful support to Abode, reinforcing a shared commitment to empowering individuals and building inclusive communities.
Across the year, J&J employees will volunteer their time to support a range of activities aimed at promoting well-being and enhancing the existing supportive environment provided by Abode. From maintenance work at the charity’s centre in Blackrock, to facilitating workshops, and carrying out fundraising initiatives to support the provision of critical services.
Pat Sheehy, Senior Director of Operations & Site CSR Sponsor, Johnson & Johnson Innovative Medicine Ringaskiddy said: “We are proud to support Abode, whose work is instrumental in enabling and empowering those living with disabilities to maximise their ability and make choices and plans to support and achieve their personal goals Their mission aligns with our commitment to transforming possibilities and improving patient outcomes, and we look forward to working with them throughout 2025 as they continue to carry out their critical work”.
Lorna Hughes, Chief Executive Officer, Abode said: “Abode is honoured to have been chosen as J&J’s charity partner for 2025. This partnership will further our mission of enabling people to live the lives of their choosing to the fullest potential and ensure that our service users continue to have the resources and support that enables their active participation in their communities.”
The charity partnership reflects J&J’s ongoing commitment to social responsibility, and to making a positive impact in the communities where its people live and work, both in Ireland and globally.
